Drug Trial Radar · NCT07775703
HS-20117-2 Injection in Patients With Advanced Solid Tumors
Last checked: Nov 19, 2026Latest source record: Aug 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Nov 13, 2025
Primary completion
Dec 30, 2027
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- Hansoh BioMedical R&D CompanyIndustry
- Sponsor type
- Industry
- First posted
- Aug 20, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is a multicenter, open-label, Phase I clinical study designed to evaluate the pharmacokinetics, safety, and tolerability of HS-20117-2 in patients with advanced solid tumors.
Conditions
- Advanced Solid Tumors
Interventions
HS-20117-2 InjectionDrug
Participants will receive subcutaneous injections of HS-20117-2 Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of PK parameters of HS-20117: CmaxTime frame: Up to Day 1 of Cycle 2(once every two weeks, each cycle is 14 days) or Day 1 of Cycle 3(once every three weeks, each cycle is 21 days)
- Evaluation of PK parameters of HS-20117: CtroughTime frame: Up to Day 1 of Cycle 2(once every two weeks, each cycle is 14 days) or Day 1 of Cycle 3(once every three weeks, each cycle is 21 days)
- Evaluation of PK parameters of HS-20117: AUC0-14dayTime frame: Up to 14 days(once every two weeks)
- Evaluation of PK parameters of HS-20117: AUC0-21dayTime frame: Up to 21 days(once every three weeks)
- Evaluation of the safety and tolerability of HS-20117-2 Injection in patients with advanced solid tumorsTime frame: Through study completion,up to 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.